Oncological-Therapy Related Oral Mucositis as an Interdisciplinary Problem-Literature Review

Aida Kusiak, Barbara Alicja Jereczek-Fossa, Dominika Cichońska, Daniela Alterio, Aida Kusiak, Barbara Alicja Jereczek-Fossa, Dominika Cichońska, Daniela Alterio

Abstract

Oral mucositis is a toxic side effect of non-surgical cancer treatments: chemotherapy and radiotherapy, which strongly impair quality of life and can not only cause strong pain, but also lead to problems with basic physiological needs as eating and swallowing. Development of oral mucositis is associated with type, dosage, and schedule of radiation or chemotherapy and other factors related to patients. Management of oral mucositis is a valid problem, requiring topical application of anesthetics, coating agents, cryotherapy, low level laser therapy, pharmacological methods as usage of keratinocyte growth factors, supplementation of vitamins, and a proper diet. Another approach to oral mucositis measurement includesphotobiomodulation, which brings analgesic and anti-inflammatory effects.Although oral mucositis is a general health issues, the role of proper dental care is essential. It should include elimination of all potential sources of mucosal injury and microorganisms inhabiting theoral cavity through oral hygiene education,professional management ofdental plaque,and treatment of the caries and periodontium, which are necessary to reduce the risk of inflammation in the oral cavity. This paper describes the possibilities of monitoring oral mucositis,taking into account the latest therapeutic achievements.

Keywords: oral cavity; oral mucosa; oral mucositis; treatment.

Conflict of interest statement

The authors declare that there is no conflict of interest.

References

    1. Al-Dasooqi N., Sonis S.T., Bowen J.M., Bateman E., Blijlevens N., Gibson R.J., Logan R.M., Nair R.G., Stringer A.M., Yazbeck R., et al. Emerging evidence on the pathobiology of mucositis. Support. Care Cancer. 2013;21:3233–3241. doi: 10.1007/s00520-013-1900-x.
    1. Alterio D., Jereszek-Fossa B.A., Fiore M.R., Piperno G., Ansarin M., Orecchia R. Cancer Treatment-induced Oral Mucositis. Anticancer Res. 2007;27:1105–1126.
    1. Bockel S., Vallard A., Levy A., Francois S., Bourdis M., Le Gallic C., Riccobono D., Annede P., Drouet M., Tao Y., et al. Pharmacological modulation of radiation-induced oral mucosal complications. Cancer Radiother. 2018;22:429–437. doi: 10.1016/j.canrad.2017.11.006.
    1. Scully C., Sonis S., Diz P.D. Oral mucositis. Oral Dis. 2006;12:229–241. doi: 10.1111/j.1601-0825.2006.01258.x.
    1. Sonis S.T. Oral mucositis. Anticancer Drugs. 2011;22:607–612. doi: 10.1097/CAD.0b013e3283462086.
    1. Elting L.S., Cooksley C.D., Chambers M.S., Garden A.S. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with headand- neck malignancies. Int. J. Radiat. Oncol. Biol. Phys. 2007;68:1110–1120. doi: 10.1016/j.ijrobp.2007.01.053.
    1. Vera-Llonch M., Oster G., Hagiwara M., Sonis S. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer. 2006;106:329–336. doi: 10.1002/cncr.21622.
    1. Saadeh C.E. Chemotherapy- and radiotherapy-induced oral mucositis: Review of preventive strategies and treatment. Pharmacotherapy. 2005;25:540–554. doi: 10.1592/phco.25.4.540.61035.
    1. Elting L.S., Cooksley C., Chambers M., Cantor S.B., Manzullo E., Rubenstein E.B. The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy induced mucositis. Cancer. 2003;98:1531–1539. doi: 10.1002/cncr.11671.
    1. Trotti A., Bellm L.A., Epstein J.B., Frame D., Fuchs H.J., Gwede C.K., Komaroff E., Nalysnyk L., Zilberberg M.D. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review. Radiother. Oncol. 2003;66:253–262. doi: 10.1016/S0167-8140(02)00404-8.
    1. Sonis S.T. Pathobiology of oral mucositis: Novel insights and opportunities. J. Support. Oncol. 2007;5:3–11.
    1. Sonis S.T. New thoughts on the initiation of mucositis. Oral Dis. 2010;16:597–600. doi: 10.1111/j.1601-0825.2010.01681.x.
    1. Sonis S.T. The biologic role for nuclear factor-kappaB in disease and its potential involvement in mucosal injury associated with anti-neoplastic therapy. Crit. Rev. Oral Biol. Med. 2002;13:380–389. doi: 10.1177/154411130201300502.
    1. Sonis S.T. The pathobiology of mucositis. Nat. Rev. Cancer. 2004;4:277–284. doi: 10.1038/nrc1318.
    1. Sonis S.T. Mucositis: The impact, biology and therapeutic opportunities of oral mucositis. Oral Oncol. 2009;45:1015–1020. doi: 10.1016/j.oraloncology.2009.08.006.
    1. Sonis S.T. A biological approach to mucositis. J. Support. Oncol. 2004;2:21–32.
    1. Igawa M., Kadena H., Ueda M., Usui T. Association between patient characteristics and treatment history, and toxicity associated with methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) for advanced urothelial cancer. Br. J. Urol. 1994;73:263–267. doi: 10.1111/j.1464-410X.1994.tb07515.x.
    1. Sloan J.A., Loprinzi C.L., Novotny P.J., Okuno S., Nair S., Barton D.L. Sex differences in fluorouracil-induced stomatitis. J. Clin. Oncol. 2000;18:412–420. doi: 10.1200/JCO.2000.18.2.412.
    1. Damascena L.C.L., De Lucena N.N.N., Ribeiro I.L.A., De Araujo T.L.P., De Castro R.D., Bonan P.R.F., Lima Neto E.D.A., De Araújo-Filho L.M., Valença A.M.G. Factors Contributing to the Duration of Chemotherapy-Induced Severe Oral Mucositis in Oncopediatric Patients. Int. J. Environ. Res. Public Health. 2018;15:1153. doi: 10.3390/ijerph15061153.
    1. Sonis S.T., Eilers J.P., Epstein J.B., Le Veque F.G., Liggett W.H., Jr., Mulagha M.T., Peterson D.E., Rose A.H., Schubert M.M., Spijkervet F.K. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Cancer. 1999;85:2103–2113. doi: 10.1002/(SICI)1097-0142(19990515)85:10<2103::AID-CNCR2>;2-0.
    1. Keefe D.M., Schubert M.M., Elting L.S., Sonis S.T., Epstein J.B., Raber-Durlacher J.E., Migliorati C.A., McGuire D.B., Hutchins R.D., Peterson D.E. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer. 2007;109:820–831. doi: 10.1002/cncr.22484.
    1. Olsen K., Hanson J., Hamilton J., Stacey D., Eades M., Gue D. Assessing the reliability and validity of the revised WCCNR stomatitis staging system for cancer therapy-induced stomatitis. Can. Oncol. Nurs. J. 2004;14:168–174. doi: 10.5737/1181912x143168174.
    1. Eilers J., Berger A.M., Petersen M.C. Development, testing, and application of the oral assessment guide. Oncol. Nurs. Forum. 1988;15:325–330.
    1. Sonis S.T. Oral Mucositis. Springer Healthcare; Berlin, Germany: 2012.
    1. Peterson D.E., Srivastava R., Lalla R.V. Oral mucosal injury in oncology patients: Perspectives on maturation of a field. Oral Dis. 2015;21:133–141. doi: 10.1111/odi.12167.
    1. Elting L.S., Keefe D.M., Sonis S.T., Garden A.S., Spijkervet F.K., Barasch A., Tishler R.B., Canty T.P., Kudrimoti M.K., Vera-Llonch M. Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: Demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life. Cancer. 2008;113:2704–2713. doi: 10.1002/cncr.23898.
    1. Nonzee N.J., Dandade N.A., Patel U., Markossian T., Agulnik M., Argiris A., Patel J.D., Kern R.C., Munshi H.G., Calhoun E.A., et al. Evaluating the Supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis: Results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a veterans Administration hospital, or a comprehensive cancer care center. Cancer. 2008;113:1446–1452.
    1. Sonis S.T., Oster G., Fuchs H., Bellm L., Bradford W.Z., Edelsberg J., Hayden V., Eilers J., Epstein J.B., LeVeque F.G., et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J. Clin. Oncol. 2001;19:2201–2205. doi: 10.1200/JCO.2001.19.8.2201.
    1. Djuric M., Hillier-Kolarov V., Belic A., Jankovic L. Mucositis prevention by improved dental care in acute leukemia patients. Support. Care Cancer. 2006;14:137–146. doi: 10.1007/s00520-005-0867-7.
    1. Scully C., Epstein J., Sonis S. Oral mucositis: A challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: Diagnosis and management of mucositis. Head Neck. 2004;26:77–84. doi: 10.1002/hed.10326.
    1. Lalla R.V., Sonis S.T., Peterson D.E. Management of Oral Mucositis in Patients Who Have Cancer. Dent. Clin. North Am. 2008;52:61–77. doi: 10.1016/j.cden.2007.10.002.
    1. Bensinger W., Schubert M., Ang K.K., Brizel D., Brown E., Eilers J.G., Elting L., Mittal B.B., Schattner M.A., Spielberger R., et al. NCCN Task Force Report: Prevention and management of mucositis in cancer care. J. Natl. Compr. Cancer Netw. 2008;6(Suppl. S1):S1–S21.
    1. Barasch A., Elad S., Altman A., Damato K., Epstein J. Antimicrobials, mucosal coating agents, anesthetics, analgesics, and nutritional supplements for alimentary tract mucositis. Support. Care Cancer. 2006;14:528–532. doi: 10.1007/s00520-006-0066-1.
    1. High K.P., Legault C., Sinclair J.A., Cruz J., Hill K., Hurd D.D. Low plasma concentrations of retinol and alpha-tocopherol in hematopoietic stem cell transplant recipients: The effect of mucositis and the risk of infection. Am. J. Clin. Nutr. 2002;76:1358–1366. doi: 10.1093/ajcn/76.6.1358.
    1. Chang J.E., Min S.W., Kim C.S., Han S.H., Kwon Y.S., Hwang J.Y. Effect of prophylactic benzydamine hydrochloride on post- operative sore throat and hoarseness after tracheal intubation using a double-lumen endobronchial tube: A randomized controlled trial. Can. J. Anaesth. 2015;62:1097–1103. doi: 10.1007/s12630-015-0432-x.
    1. Ariyawardana A., Cheng K.K.F., Kandwal A., Tilly V., Al-Azri A.R., Galiti D., Chiang K., Vaddi A., Ranna V., Nicolatou-Galitis O., et al. Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients and clinical practice guidelines. Support. Care Cancer. 2019;27:3985–3995. doi: 10.1007/s00520-019-04888-w.
    1. Saunders D.P., Rouleau T., Cheng K., Yarom N., Kandwal A., Joy J., BektasKayhan K., van de Wetering M., Brito-Dellan N., Kataoka T., et al. Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients and clinical practice guidelines. Support. Care Cancer. 2020;28:2473–2484. doi: 10.1007/s00520-019-05181-6.
    1. Yarom N., Hovan A., Bossi P., Ariyawardana A., Jensen S.B., Gobbo M., Saca-Hazboun H., Kandwal A., Majorana A., Ottaviani G., et al. Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: Vitamins, minerals, and nutritional supplements. Support. Care Cancer. 2019;27:3997–4010. doi: 10.1007/s00520-019-04887-x.
    1. Molan P.C. The evidence supporting the use of honey as a wound dressing. Int. J. Low. Extrem. Wounds. 2006;5:40–54. doi: 10.1177/1534734605286014.
    1. Willix D.J., Molan P.C., Harfoot C.G. A comparison of the sensitivity of wound-infecting species of bacteria to the antibacte- rial activity of manuka honey and other honey. J. Appl. Bacteriol. 1992;73:388–394. doi: 10.1111/j.1365-2672.1992.tb04993.x.
    1. Yarom N., Hovan A., Bossi P., Ariyawardana A., Jensen S.B., Gobbo M., Saca-Hazboun H., Kandwal A., Majorana A., Ottaviani G., et al. Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines—Part 2: Honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agents. Support. Care Cancer. 2020;10:3997–4010. doi: 10.1007/s00520-019-05256-4.
    1. Aisa Y., Mori T., Kudo M., Yashima T., Kondo S., Yokoyama A., Ikeda Y., Okamoto S. Oral cryotherapy forthe prevention of high-dosemelphalan induced stomatitis in allogeneic hematopoietic stem cell transplant recipients. Support. Care Cancer. 2005;13:266–269. doi: 10.1007/s00520-004-0726-y.
    1. Askarifar M., Lakdizaji S., Ramzi M., Rahmani A., Jabbarzadeh F. The effects of oral cryotherapy on chemotherapy-induced oral mucositis in patients undergoing autologous transplantation of blood stem cells: A clinical trial. Iran. Red Crescent Med. J. 2016;18:e24775. doi: 10.5812/ircmj.24775.
    1. Lu Y., Zhu X., Ma Q., Wang J., Jiang P., Teng S., Zhou L., Wu D., Wang H. Oral cryotherapy for oral mucositis management in patients receiving allogeneic hematopoietic stem cell transplantation: A prospective randomized study. Support. Care Cancer. 2020;28:1747–1754. doi: 10.1007/s00520-019-04966-z.
    1. Kamsvåg T., Svanberg A., Legert K.G., Arvidson J., von Essen L., Mellgren K., Toporski J., Winiarski J., Ljungman G. Prevention of oral mucositis with cryotherapy in children undergoing hematopoietic stem cell transplantations-a feasibility study and randomized controlled trial. Support. Care Cancer. 2020;28:1–11.
    1. Zecha J.A., Raber-Durlacher J.E., Nair R.G., Epstein J.B., Sonis S.T., Elad S., Hamblin M.R., Barasch A., Migliorati C.A., Milstein D.M., et al. Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: Part 1: Mechanisms of action, dosimetric, and safety considerations. Support. Care Cancer. 2016;24:2781–2792. doi: 10.1007/s00520-016-3152-z.
    1. Zecha J.A., Raber-Durlacher J.E., Nair R.G., Epstein J.B., Elad S., Hamblin M.R., Barasch A., Migliorati C.A., Milstein D.M., Genot M.T., et al. Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: Part 2: Proposed applications and treatment protocols. Support. Care Cancer. 2016;24:2793–2805. doi: 10.1007/s00520-016-3153-y.
    1. Lubart R., Eichler M., Lavi R., Friedman H., Shainberg A. Low-energy laser irradiation promotes cellular redox activity. Photomed. Laser Surg. 2005;23:3–9. doi: 10.1089/pho.2005.23.3.
    1. Migliorati C., Hewson I., Lalla R.V. Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients. Support. Care Cancer. 2013;21:333–341. doi: 10.1007/s00520-012-1605-6.
    1. He M., Zhang B., Shen N., Wu N., Sun J. A systematic review and meta-analysis of the effect of low-level laser therapy (LLLT) on chemotherapy-induced oral mucositis in pediatric and young patients. Eur. J. Pediatrics. 2018;177:7–17. doi: 10.1007/s00431-017-3043-4.
    1. Bjordal J.M., Bensadoun R.J., Tunèr J., Frigo L., Gjerde K., Lopes-Martins R.A. A systematic review with meta-analysis of the effect of low-level laser therapy (LLLT) in cancer therapy-induced oral mucositis. Support. Care Cancer. 2011;19:1069–1077. doi: 10.1007/s00520-011-1202-0.
    1. Gautam A.P., Fernandes D.J., Vidyasagar M.S., Maiya A.G., Guddattu V. Low level laser therapy against radiation induced oral mucositis in elderly head and neck cancer patients-a randomized placebo controlled trial. J. Photochem. Photobiol. B. 2015;144:51–56. doi: 10.1016/j.jphotobiol.2015.01.011.
    1. Oton-Leite A.F., Silva G.B., Morais M.O., Silva T.A., Leles C.R., Valadares M.C., Pinezi J.C., Batista A.C., Mendonca E.F. Effect of low-level laser therapy on chemoradiotherapy-induced oral mucositis and salivary inflammatory mediators in head and neck cancer patients. Lasers Surg. Med. 2015;47:296–305. doi: 10.1002/lsm.22349.
    1. Antunes H.S., Herchenhorn D., Small I.A., Araujo C.M., Viegas C.M., Cabral E., Rampini M.P., Rodrigues P.C., Silva T.G., Ferreira E.M., et al. Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation. Radiother. Oncol. 2013;109:297–302. doi: 10.1016/j.radonc.2013.08.010.
    1. Rezk-Allah S.S., AbdElshaf H.M., Farid R.J., Hassan M.A.E., Alsirafy S.A. Effect of Low-Level Laser Therapy in Treatment of Chemotherapy Induced Oral Mucositis. J. Lasers Med. Sci. 2019;10:125–130. doi: 10.15171/jlms.2019.20.
    1. Zadik Y., Arany P.R., Fregnani E.R., Bossi P., Antunes H.S., Bensadoun R.J., Gueiros L.A., Majorana A., Nair R.G., Ranna V., et al. Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines. Support. Care Cancer. 2019;27:3969–3983. doi: 10.1007/s00520-019-04890-2.
    1. Guedes C.D.C.F.V., de Freitas Filho S.A.J., de Faria P.R., Loyola A.M., Sabino-Silva R., Cardoso S.V. Variation of Energy in Photobiomodulation for the Control of Radiotherapy-Induced Oral Mucositis: A Clinical Study in Head and Neck Cancer Patients. Int. J. Dent. 2018;22:270–279. doi: 10.1155/2018/4579279.
    1. Finch P.W., Rubin J.S. Keratinocyte growth factor/fibroblast growth factor 7, a homeostatic factor with therapeutic potential for epithelial protection and repair. Adv. Cancer Res. 2004;91:69–136.
    1. Spielberger R., Stiff P., Bensinger W., Gentile T., Weisdorf D., Kewalramani T., Shea T., Yanovich S., Hansen K., Noga S., et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N. Engl. J. Med. 2004;351:2590–2598. doi: 10.1056/NEJMoa040125.
    1. Vadhan-Raj S., Trent J., Patel S., Zhou X., Johnson M.M., Araujo D., Ludwig J.A., O’Roark S., Gillenwater A.M., Bueso-Ramos C., et al. Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: A randomized trial. Ann. Intern. Med. 2010;153:358–367. doi: 10.7326/0003-4819-153-6-201009210-00003.
    1. Henke M., Alfonsi M., Foa P., Giralt J., Bardet E., Cerezo L., Salzwimmer M., Lizambri R., Emmerson L., Chen M.G., et al. Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: A randomized, placebo-controlled trial. J. Clin. Oncol. 2011;29:2815–2820. doi: 10.1200/JCO.2010.32.4103.
    1. Le Q.T., Kim H.E., Schneider C.J., Muraközy G., Skladowski K., Reinisch S., Chen Y., Hickey M., Mo M., Chen M.G., et al. Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: A randomized, placebo-controlled study. J. Clin. Oncol. 2011;29:2808–2814. doi: 10.1200/JCO.2010.32.4095.
    1. Stiff P.J., Leinonen M., Kullenberg T., Rudebeck M., Chateau M., Spielberger R. Long-Term Safety Outcomes in Patients with Hematological Malignancies Undergoing Autologous Hematopoietic Stem Cell Transplantation Treated with Palifermin to Prevent Oral Mucositis. Biol. Blood Marrow Transplant. 2016;22:164–169. doi: 10.1016/j.bbmt.2015.08.018.
    1. Quinn B. Efficacy of a supersaturated calcium phosphate oral rinse for the prevention and treatment of oral mucositis in patients receiving high-dose cancer therapy: A review of current data. Eur. J. Cancer Care. 2013;22:564–579. doi: 10.1111/ecc.12073.
    1. Papas A.S., Clark R.E., Martuscelli G., O’Loughlin K.T., Johansen E., Miller K.B. A prospective, randomized trial for the prevention of mucositis in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant. 2003;31:705–712. doi: 10.1038/sj.bmt.1703870.
    1. Raphael M.F., den Boer A.M., Kollen W.J., Mekelenkamp H., Abbink F.C., Kaspers G.J., Zomer-Kooijker K., Molmans B.H., Tissing W.J. Caphosol, a therapeutic option in case of cancer therapy-induced oral mucositis in children? Results from a prospective multicenter double blind randomized controlled trial. Support. Care Cancer. 2014;22:3–6. doi: 10.1007/s00520-013-2015-0.
    1. Rao N.G., Trotti A., Kim J., Schell M.J., Zhao X., Amdur R.J., Rosenthal D.I. Phase II multicenter trial of Caphosol for the reduction of mucositis in patients receiving radiation therapy for head and neck cancer. Oral Oncol. 2014;50:765–769. doi: 10.1016/j.oraloncology.2014.06.001.
    1. Treister N., Nieder M., Baggott C., Olson E., Chen L., Dang H., Krailo M., August A., Sung L. Caphosol for prevention of oral mucositis in pediatric myeloablativehaematopoieticcell transplantation. Br. J. Cancer. 2017;116:21–27. doi: 10.1038/bjc.2016.380.
    1. Svanberg A., Öhrn K., Birgegård G. Caphosol® mouthwash gives no additional protection against oral mucositis compared to cryotherapy alone in stem cell transplantation. A pilot study. Eur. J. Oncol. Nurs. 2015;19:50–53. doi: 10.1016/j.ejon.2014.07.011.
    1. Alterio D., Marvaso G., Ferrari A., Volpe S., Orecchia R., Jereczek-Fossa B. Modern radiotherapy for head and neck cancer. Semin. Oncol. 2019;46:233–245. doi: 10.1053/j.seminoncol.2019.07.002.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe